163 related articles for article (PubMed ID: 17350410)
1. Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme.
BriceƱo E; Calderon A; Sotelo J
Surg Neurol; 2007 Apr; 67(4):388-91. PubMed ID: 17350410
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme.
Hsieh PC; Chandler JP; Bhangoo S; Panagiotopoulos K; Kalapurakal JA; Marymont MH; Cozzens JW; Levy RM; Salehi S
Neurosurgery; 2005 Oct; 57(4):684-92; discussion 684-92. PubMed ID: 16239880
[TBL] [Abstract][Full Text] [Related]
3. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
McLendon RE; Halperin EC
Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892
[TBL] [Abstract][Full Text] [Related]
4. Survival trends in elderly patients with glioblastoma multiforme: resective surgery, radiation, and chemotherapy.
Patwardhan RV; Shorter C; Willis BK; Reddy P; Smith D; Caldito GC; Nanda A
Surg Neurol; 2004 Sep; 62(3):207-13; discussion 214-5. PubMed ID: 15336860
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of 205 patients with glioblastoma multiforme: clinical characteristics, treatment and prognosis in China.
Ma X; Lv Y; Liu J; Wang D; Huang Q; Wang X; Li G; Xu S; Li X
J Clin Neurosci; 2009 Dec; 16(12):1595-8. PubMed ID: 19793663
[TBL] [Abstract][Full Text] [Related]
6. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme.
McGirt MJ; Mukherjee D; Chaichana KL; Than KD; Weingart JD; Quinones-Hinojosa A
Neurosurgery; 2009 Sep; 65(3):463-9; discussion 469-70. PubMed ID: 19687690
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma multiforme: evidence-based approach to therapy.
Nicholas MK
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
[TBL] [Abstract][Full Text] [Related]
8. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
9. Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination.
Wheeler CJ; Das A; Liu G; Yu JS; Black KL
Clin Cancer Res; 2004 Aug; 10(16):5316-26. PubMed ID: 15328167
[TBL] [Abstract][Full Text] [Related]
10. Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme.
Kase M; Vardja M; Lipping A; Asser T; Jaal J
Radiother Oncol; 2011 Oct; 101(1):127-31. PubMed ID: 21775006
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases.
Tait MJ; Petrik V; Loosemore A; Bell BA; Papadopoulos MC
Br J Neurosurg; 2007 Oct; 21(5):496-500. PubMed ID: 17852105
[TBL] [Abstract][Full Text] [Related]
12. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
Kong DS; Nam DH; Lee JI; Park K; Kim JH
J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347
[TBL] [Abstract][Full Text] [Related]
13. Patterns of care in elderly glioblastoma patients.
Iwamoto FM; Reiner AS; Panageas KS; Elkin EB; Abrey LE
Ann Neurol; 2008 Dec; 64(6):628-34. PubMed ID: 19107984
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
De Vleeschouwer S; Fieuws S; Rutkowski S; Van Calenbergh F; Van Loon J; Goffin J; Sciot R; Wilms G; Demaerel P; Warmuth-Metz M; Soerensen N; Wolff JE; Wagner S; Kaempgen E; Van Gool SW
Clin Cancer Res; 2008 May; 14(10):3098-104. PubMed ID: 18483377
[TBL] [Abstract][Full Text] [Related]
15. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
Glas M; Hundsberger T; Stuplich M; Wiewrodt D; Kurzwelly D; Nguyen-Huu B; Rasch K; Herrlinger U
Oncology; 2009; 76(3):184-9. PubMed ID: 19218824
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
17. Microscopic thrombi in glioblastoma multiforme do not predict the development of deep venous thrombosis.
Prayson NF; Angelov L; Prayson RA
Ann Diagn Pathol; 2009 Oct; 13(5):291-6. PubMed ID: 19751904
[TBL] [Abstract][Full Text] [Related]
18. Short course of radiation therapy in elderly patients with glioblastoma multiforme.
Idbaih A; Taillibert S; Simon JM; Psimaras D; Schneble HM; Lopez S; Lang P; Toubiana T; Feuvret L; Delattre JY; Mazeron JJ
Cancer Radiother; 2008 Dec; 12(8):788-92. PubMed ID: 19046921
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of treatment for glioblastoma multiforme in elderly patients (65+): a retrospective analysis.
Kushnir I; Tzuk-Shina T
Isr Med Assoc J; 2011 May; 13(5):290-4. PubMed ID: 21845970
[TBL] [Abstract][Full Text] [Related]
20. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma.
Brockmann MA; Giese A; Mueller K; Kaba FJ; Lohr F; Weiss C; Gottschalk S; Nolte I; Leppert J; Tuettenberg J; Groden C
Neuro Oncol; 2007 Jul; 9(3):335-42. PubMed ID: 17504931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]